SKYE
Skye Bioscience, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.92
+7.87%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
—
Return on equity
-457.6%
Return on assets
—
Return on invested capital
0.00x
Asset turnover
-$38.8M
Cash from operations
$2.27
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026